Exploring Maternal Mental Health and Neonatal Risks in SSRI Study – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
” In a large national cohort from Finland (over 1.2 million births), SSRI exposure was linked to:
- Lower risks of very preterm birth and low birth weight
- Higher risk of neonatal adaptation symptoms (eg, breathing problems, low 5-minute Apgar, neonatal care)
- Persistent increased risk of gestational diabetes
Takeaway: SSRI use during pregnancy has complex, independent effects — balancing maternal mental health benefits with neonatal adaptation considerations.
Read the full text to learn more.”
Proceed to the video attached to the post.
Title: SSRI use during pregnancy and maternal depression – a nationwide birth cohort study on risks to the mother and the newborn
Authors: Heli Malm, Alan S. Brown, Keely Cheslack-Postava, Mika Gissler, David Gyllenberg, Emmi Heinonen, Susanna Hinkka-Yli-Salomäki, Ian W. McKeague, Aleksi Tornio, Subina Upadhyaya, Andre Sourander
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 14, 2026, 15:25Beyond Embryo Morphology: Can 2 Embryos Influence Each Other’s Implantation Through Endometrial Crosstalk?
-
Oct 14, 2026, 15:01Nitiz Murdia: 5,000 Indian Rupees and a 2-Room Fertility Clinic in 1988…
-
Oct 14, 2026, 14:58Devyanshi Dixit։ Can We Measure Ovarian Age?
-
Oct 14, 2026, 14:56Rohit Gutgutia: The IVF Price War, and Who Really Pays for It
-
Oct 14, 2026, 14:54Abdullah F. Edrees։ Marking an Important Milestone for IVF
-
Oct 14, 2026, 14:50Gregory Poulos: Pleased to Be Named President of Vios Fertility 2.0
-
Oct 13, 2026, 16:58Slavian Bumbu: A Low AMH Is Not an Infertility Diagnosis
-
Oct 13, 2026, 16:43Keshav Malhotra: No Embryologist or Laboratory Technique Can Guarantee Euploid Embryos
-
Oct 13, 2026, 16:37Tony Gordon: What Is the Most Successful Form of Fertility Treatment?